ALX Oncology Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	22.41	48.82	363.67	434.22	9.02	8.26
Short-Term Investments	160.33	217.39	0	0	0	0
Cash & Cash Equivalents	182.74	266.21	363.67	434.22	9.02	8.26
Cash Growth	-31.36%	-26.80%	-16.25%	4715.56%	9.14%	-
Receivables	0	0	0	0	0.54	0.93
Other Current Assets	5.92	4.76	3.35	1.77	0.26	1.01
Total Current Assets	188.66	270.97	367.02	435.99	9.81	10.21
Property, Plant & Equipment	3.59	3.89	0.9	0.05	0.86	0.96
Long-Term Investments	35.41	16.7	0	0	0	0
Other Long-Term Assets	14.89	14.93	12.27	0.01	0.01	0
Total Long-Term Assets	53.89	35.52	13.16	0.06	0.87	0.96
Total Assets	242.55	306.49	380.18	436.05	10.68	11.16
Accounts Payable	9.13	9.72	5.39	0.08	3.75	0.7
Other Current Liabilities	26.87	18.6	9.9	6.13	1.24	1.18
Total Current Liabilities	36	28.33	15.3	6.2	4.98	1.87
Long-Term Debt	9.64	9.39	0	0	5.42	0
Other Long-Term Liabilities	7.2	5.31	1.84	0.01	0.55	0.14
Total Long-Term Liabilities	16.84	14.7	1.84	0.01	5.97	0.14
Total Liabilities	52.84	43.03	17.13	6.21	10.95	2.01
Total Debt	9.64	9.39	0	0	5.42	0
Debt Growth	2.66%	-	-	-	-	-
Retained Earnings	-486.27	-325.47	-201.99	-118.52	-72.78	-53.54
Comprehensive Income	0.26	-0.85	0	0	0	0
Shareholders' Equity	189.71	263.46	363.05	429.85	-70.64	-51.78
Net Cash / Debt	173.1	256.82	363.67	434.22	3.6	8.26
Net Cash / Debt Growth	-32.60%	-29.38%	-16.25%	11975.06%	-56.48%	-
Net Cash Per Share	4.03	6.31	9.02	23.49	1.17	3.00
Working Capital	152.66	242.64	351.72	429.79	4.83	8.34
Book Value Per Share	4.41	6.47	9.01	23.25	-22.96	-18.82

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).